Asembia 任命专科药房资深人士 David Skomo 为首席执行官

Seasoned Specialty Pharmacy Executive to Build on Asembia's Commitment to
Clinical Excellence and Innovation

, /PRNewswire/ -- Asembia, a leading provider of end-to-end, technology-enabled commercialization solutions for the specialty pharmaceutical industry, today announced the appointment of David Skomo as Chief Executive Officer. Skomo succeeds Lawrence Irene, co-founder of Asembia, and will lead the company's next phase of growth by investing in technology, marketing, and operational initiatives to serve more patients, prescribers, pharmacies, and pharma companies.

Skomo brings more than three decades of specialty pharmacy, PBM and pharma services experience helping patients access innovative drug therapies. To lead Asembia in its next phase of accelerated growth and innovation, Skomo brings deep industry knowledge, specialty pharmacy expertise, and a strong track record of growth. As CEO, Skomo will focus on strengthening and investing in Asembia's commercial capabilities, technology platform, and pharmacy services through both organic growth and strategic acquisitions.

"I am honored to join Asembia at such an exciting time for the company and the specialty pharma industry," said Skomo. "I want to thank Larry for his leadership and vision for Asembia's growth, and I am excited for what's ahead. I look forward to working with the company's employees, customers and partners to build on Asembia's strong foundation, accelerate innovation and create greater value across the specialty pharma ecosystem."

David Skomo joins Asembia from WellDyne, where he most recently served as Chief Operating Officer and Division President of HealthDyne, overseeing home delivery pharmacy, specialty pharmacy services, PBM operations, customer care, and HealthDyne sales and client services. He previously held senior positions at OptumRx, CVS, and Diplomat. 

"David's experience, passion and deep understanding of the specialty pharma ecosystem make him the right leader for Asembia's next chapter of growth," said Spencer Moore, Asembia Board Member. "We are confident that, under David's leadership, Asembia will continue to innovate, grow and deliver meaningful value for patients, pharmacies and pharma companies."

About Asembia

Headquartered in Florham Park, NJ, Asembia is a leading provider of technology-enabled commercialization solutions for specialty pharma to pharmaceutical manufacturers, pharmacies, patients, and prescribers. The Company's solution set includes patient support HUB services, specialty distribution, data services, pharmacy software, and group purchasing ("GPO") solutions. Through deep industry connectivity, strong stakeholder relationships, and a tailored approach to value creation, Asembia helps improve access to therapy and enhances millions of patient experiences each year. For further information about Asembia, please visit www.asembia.com.

Media Contact:
Bill Fitzgerald
VP Marketing
Asembia
P: 973-564-8004
E: [email protected]

SOURCE Asembia